TASE
AllMeD is an Israeli public company listed on the Tel Aviv Stock Exchange. Below you will find the company’s current financial reports and immediate reports as published on the TASE website.
5.2.2026
Allmed Solutions – Supplementary report regarding a Private Share Issuance and the allotment of approx. 3.9M shares to two offerees for an aggregate consideration of approx. $500,000.
https://maya.tase.co.il/he/reports/companies/1721181
18.12.2025
Allmed Solutions – TruLeaf (Subsidiary) received Ethics Committee approval for human clinical trials in South Africa involving the implantation of a Mitral Heart Valve system.
https://maya.tase.co.il/he/reports/1710561
Allmed Solutions – TruLeaf (Subsidiary) was awarded an R&D grant of approx. NIS 1.4M from the Israel Innovation Authority (IIA).
https://maya.tase.co.il/he/reports/1710128
7.12.2025
Allmed Solutions – Completion of Phase I in the human implantation procedure of TruLeaf’s docking system for the 4th patient.
https://maya.tase.co.il/he/reports/1708074
3.12.2025
Allmed Solutions – TruLeaf (Subsidiary) performed Phase II (valve-in-docking-station implantation) in two patients.
https://maya.tase.co.il/he/reports/1707593
3.12.2025
Allmed Solutions – Update regarding the execution of Phase I in the human implantation procedure of the docking system.
https://maya.tase.co.il/he/reports/1707585
7.9.2025
Allmed Solutions – TruLeaf (Subsidiary) performed the first-in-human (FIH) implantation of the RoseDoc valve docking system.
https://maya.tase.co.il/he/reports/1691033
13.8.2025
Allmed Solutions – Publication of the Reviewed Financial Statements for the second quarter and first half of 2025.
https://maya.tase.co.il/he/reports/1685529
18.3.2025
Allmed Solutions – Publication of the Audited Annual and Periodic Reports for the fiscal year 2024.
https://maya.tase.co.il/he/reports/1651949
5.3.2025
Allmed Solutions – Further to the MOU between TruLeaf and a third party, it was agreed to suspend discussions regarding the potential transaction.
https://maya.tase.co.il/he/reports/1649343
28.1.2025
Allmed Solutions – Extension of the Memorandum of Understanding (MOU) and negotiation period for an additional three months.
https://maya.tase.co.il/he/reports/1643486
Warning: All data, documents, links and programs available on this World Wide Web site are sent to you for information only. Under no circumstances may they be used or considered as an offer to sell or as seeking an application to buy securities or derivatives. Although the information, links and programs contained in this World Wide Web site have been obtained from sources considered to be reliable, we guarantee neither their accuracy nor their completeness.
For full information about the company, please refer to the websites of the Israel Securities Authority and the Tel Aviv Stock Exchange Ltd. at: